Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.


Journal

Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341

Informations de publication

Date de publication:
09 2022
Historique:
received: 09 03 2022
accepted: 27 03 2022
pubmed: 17 4 2022
medline: 14 9 2022
entrez: 16 4 2022
Statut: ppublish

Résumé

The clinical presentation of Parkinson's disease (PD) is both complex and heterogeneous, and its precise classification often requires an intensive work-up. The differential diagnosis, assessment of disease progression, evaluation of therapeutic responses, or identification of PD subtypes frequently remains uncertain from a clinical point of view. Various tissue- and fluid-based biomarkers are currently being investigated to improve the description of PD. From a clinician's perspective, signatures from blood that are relatively easy to obtain would have great potential for use in clinical practice if they fulfill the necessary requirements as PD biomarker. In this review article, we summarize the knowledge on blood-based PD biomarkers and present both a researcher's and a clinician's perspective on recent developments and potential future applications.

Identifiants

pubmed: 35428925
doi: 10.1007/s00702-022-02498-1
pii: 10.1007/s00702-022-02498-1
pmc: PMC9463345
doi:

Substances chimiques

Biomarkers 0
alpha-Synuclein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1201-1217

Informations de copyright

© 2022. The Author(s).

Références

Neurodegener Dis. 2008;5(2):55-9
pubmed: 18182779
Cells. 2021 Apr 12;10(4):
pubmed: 33921342
J Neural Transm (Vienna). 2016 Apr;123(4):401-6
pubmed: 26880022
Ann Clin Transl Neurol. 2019 Dec;6(12):2426-2436
pubmed: 31742923
Transl Oncol. 2021 Jan;14(1):100907
pubmed: 33217646
Mol Neurodegener. 2020 Jun 5;15(1):33
pubmed: 32503574
Brain. 2020 Oct 1;143(10):3077-3088
pubmed: 32830221
J Neural Transm (Vienna). 2012 Jan;119(1):39-52
pubmed: 21755462
Comput Biol Chem. 2010 Aug;34(4):215-25
pubmed: 20702140
J Neural Transm (Vienna). 2018 May;125(5):875-881
pubmed: 29435648
Front Genet. 2018 Jul 12;9:242
pubmed: 30050560
Res Social Adm Pharm. 2021 May;17(5):921-929
pubmed: 32800458
J Parkinsons Dis. 2022;12(2):571-584
pubmed: 34806619
Mov Disord. 2020 Oct;35(10):1863-1868
pubmed: 32557851
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Mov Disord. 2010 Nov 15;25(15):2508-15
pubmed: 20818670
J Neuroinflammation. 2019 Nov 11;16(1):212
pubmed: 31711508
Ann Neurol. 2019 May;85(5):777-781
pubmed: 30801759
Front Mol Neurosci. 2018 Feb 22;11:53
pubmed: 29520218
Front Neurosci. 2019 Apr 18;13:381
pubmed: 31057362
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
pubmed: 11240971
Front Neurol. 2018 Dec 18;9:1081
pubmed: 30619041
J Alzheimers Dis. 2019;72(4):1353-1361
pubmed: 31744001
FASEB J. 2006 Mar;20(3):419-25
pubmed: 16507759
Neurodegener Dis. 2019;19(5-6):204-210
pubmed: 32485710
Eur J Neurol. 2020 Jun;27(6):967-974
pubmed: 32150777
JAMA Neurol. 2019 Apr 1;76(4):470-479
pubmed: 30640364
Mov Disord. 2021 Mar;36(3):774-779
pubmed: 33278043
PLoS One. 2012;7(10):e47387
pubmed: 23082161
Neurology. 2019 Sep 10;93(11):e1104-e1111
pubmed: 31420461
J Biomed Sci. 2021 Nov 18;28(1):78
pubmed: 34794432
J Neural Transm (Vienna). 2019 Apr;126(4):423-431
pubmed: 29943229
Neurology. 2017 Mar 7;88(10):930-937
pubmed: 28179466
BMC Neurol. 2019 Apr 6;19(1):56
pubmed: 30954070
J Alzheimers Dis. 2018;62(4):1857-1863
pubmed: 29614646
Eur J Neurosci. 2016 Jan;43(1):3-16
pubmed: 26332448
J Nucl Med. 2010 Sep;51(9):1331-4
pubmed: 20720060
J Parkinsons Dis. 2015;5(4):681-97
pubmed: 26485429
Lancet Neurol. 2021 Mar;20(3):203-212
pubmed: 33609478
Ann Transl Med. 2019 Nov;7(22):637
pubmed: 31930038
Front Aging Neurosci. 2019 Dec 05;11:332
pubmed: 31866854
Neurosci Lett. 2020 Sep 25;736:135259
pubmed: 32682845
Acta Neurol Scand. 2022 Jan;145(1):30-37
pubmed: 34398474
J Neural Transm (Vienna). 2002 Mar;109(3):329-39
pubmed: 11956955
J Neuroinflammation. 2018 May 28;15(1):166
pubmed: 29807534
Front Aging Neurosci. 2021 Sep 28;13:703984
pubmed: 34650422
Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3853-3856
pubmed: 27735031
Clin Neurol Neurosurg. 2018 Mar;166:76-79
pubmed: 29408778
Parkinsonism Relat Disord. 2021 Sep;90:44-48
pubmed: 34352610
Nat Rev Neurosci. 2013 Sep;14(9):626-36
pubmed: 23900411
Sci Rep. 2020 Jun 9;10(1):9329
pubmed: 32518334
J Cancer. 2021 Oct 11;12(23):6949-6963
pubmed: 34729098
Parkinsonism Relat Disord. 2021 Oct;91:102-104
pubmed: 34555572
Neurobiol Aging. 2015 Oct;36(10):2671-3
pubmed: 26234755
Ann Neurol. 2019 Jun;85(6):835-851
pubmed: 30990912
Expert Rev Neurother. 2012 Jun;12(6):673-86
pubmed: 22650170
J Neural Transm (Vienna). 2017 Mar;124(3):353-360
pubmed: 27878377
Parkinsonism Relat Disord. 2016 Jul;28:62-7
pubmed: 27132498
Psychosomatics. 2010 Nov-Dec;51(6):474-9
pubmed: 21051678
Trends Mol Med. 2019 Aug;25(8):662-672
pubmed: 31221572
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Mov Disord. 2016 Apr;31(4):605
pubmed: 26880418
Lancet. 2021 Jun 12;397(10291):2284-2303
pubmed: 33848468
Front Neurosci. 2021 Dec 03;15:690013
pubmed: 34924923
J Parkinsons Dis. 2021;11(3):1117-1127
pubmed: 33935105
Front Neurol. 2020 Jan 21;10:1388
pubmed: 32038461
Nat Rev Genet. 2011 Nov 18;12(12):861-74
pubmed: 22094949
Int J Antimicrob Agents. 2002 Jul;20(1):1-9
pubmed: 12127705
Nat Rev Drug Discov. 2007 Apr;6(4):295-303
pubmed: 17347655
Front Neurol. 2018 Apr 16;9:234
pubmed: 29713303
J Neural Transm (Vienna). 2020 May;127(5):755-762
pubmed: 32385576
Int J Biochem Cell Biol. 2010 Nov;42(11):1775-8
pubmed: 20678581
Lancet Neurol. 2022 Jan;21(1):10-11
pubmed: 34942122
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235
pubmed: 28713158
J Neural Transm (Vienna). 2003 May;110(5):517-36
pubmed: 12721813
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
PLoS One. 2012;7(10):e46813
pubmed: 23056463
Transl Neurodegener. 2019 May 15;8:15
pubmed: 31123587
J Infect. 2019 May;78(5):339-348
pubmed: 30802469
FASEB J. 2021 Oct;35(10):e21895
pubmed: 34478572
J Neuroimmune Pharmacol. 2012 Dec;7(4):927-38
pubmed: 23054369
J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):818-824
pubmed: 28550072
Exp Neurol. 2007 Apr;204(2):583-8
pubmed: 17258710
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
Mov Disord. 2020 Dec;35(12):2201-2210
pubmed: 32853481
MDM Policy Pract. 2021 Jul 2;6(1):23814683211021380
pubmed: 34277950
Front Aging Neurosci. 2018 Apr 27;10:123
pubmed: 29755341
EPMA J. 2017 Mar 9;8(1):51-60
pubmed: 28620443
Parkinsonism Relat Disord. 2021 Apr;85:11-16
pubmed: 33639572
J Neurosci. 2010 May 26;30(21):7281-9
pubmed: 20505094
Front Neurol. 2018 Dec 21;9:1123
pubmed: 30622507
Nat Aging. 2021 Mar;1(3):309-322
pubmed: 37118411
Mov Disord. 2022 Feb;37(2):435-436
pubmed: 35040209
Neurobiol Dis. 2018 Aug;116:53-59
pubmed: 29705185
Front Aging Neurosci. 2020 Oct 08;12:553635
pubmed: 33132895
Neurology. 2013 Jan 8;80(2):169-75
pubmed: 23255825
PLoS One. 2015 Jul 28;10(7):e0134118
pubmed: 26218286
Front Neurol. 2019 Apr 17;10:384
pubmed: 31057478
Clin Transl Med. 2021 Apr;11(4):e357
pubmed: 33931970
J Neural Transm (Vienna). 2022 Mar;129(3):295-300
pubmed: 35072765
Neuron. 2018 Jan 17;97(2):263-268
pubmed: 29346749
Sci Rep. 2018 Nov 26;8(1):17368
pubmed: 30478269
Front Aging Neurosci. 2020 Apr 28;12:112
pubmed: 32410983
Curr Neurol Neurosci Rep. 2021 Mar 8;21(4):17
pubmed: 33686495
Mov Disord. 2020 Nov;35(11):1999-2008
pubmed: 32798333
J Clin Neurosci. 2018 Dec;58:30-33
pubmed: 30454693
Brain Behav Immun. 2020 Oct;89:668-674
pubmed: 32688028
Arch Neurol. 2010 Nov;67(11):1350-6
pubmed: 21060011
Front Neurosci. 2017 Oct 06;11:555
pubmed: 29056899
J Neural Transm (Vienna). 2004 Feb;111(2):201-16
pubmed: 14767723
Intensive Care Med Exp. 2019 Dec 10;7(1):70
pubmed: 31823128
Oxid Med Cell Longev. 2014;2014:208408
pubmed: 25587378
Mov Disord. 2021 Mar;36(3):594-598
pubmed: 33749922
Sci Rep. 2021 Jan 27;11(1):2316
pubmed: 33504893
J Neuroinflammation. 2018 Jul 12;15(1):205
pubmed: 30001736
Neurology. 2014 May 20;82(20):1784-90
pubmed: 24748671
Parkinsonism Relat Disord. 2009 May;15(4):318-20
pubmed: 18672391
Front Aging Neurosci. 2014 Mar 31;6:53
pubmed: 24744728
Mov Disord. 2021 Oct;36(10):2426-2430
pubmed: 34101890
Neurology. 2016 Feb 9;86(6):566-76
pubmed: 26764028
Front Neurol. 2021 Aug 09;12:710572
pubmed: 34475849
Adv Clin Exp Med. 2020 Jan;29(1):115-121
pubmed: 31990459
Neurol Sci. 2015 Mar;36(3):423-8
pubmed: 25288159
Front Neurosci. 2018 Sep 05;12:625
pubmed: 30233304
Front Genet. 2019 May 16;10:452
pubmed: 31156708
Lancet Neurol. 2020 Jan;19(1):71-80
pubmed: 31678032
Mov Disord. 2021 Dec;36(12):2945-2950
pubmed: 34480363
Neurology. 2019 Mar 26;92(13):e1479-e1486
pubmed: 30814322
Resuscitation. 2013 Mar;84(3):351-6
pubmed: 22885094
Neurosci Lett. 2015 Jul 10;599:115-9
pubmed: 25998655
Nat Rev Neurol. 2021 Jun;17(6):349-361
pubmed: 33879872
Mov Disord. 2019 Jan;34(1):67-77
pubmed: 30468694
Acta Neuropathol. 2014 Nov;128(5):639-650
pubmed: 24997849
Mov Disord. 2020 Feb;35(2):288-295
pubmed: 31737952
Parkinsonism Relat Disord. 2014 Jun;20(6):590-5
pubmed: 24661464
Eur J Neurol. 2013 Jan;20(1):102-8
pubmed: 22852790
Neurol Res. 2016 Feb;38(2):98-102
pubmed: 27078697
Sci Rep. 2013;3:2540
pubmed: 23985836
Mol Neurobiol. 2018 Feb;55(2):1488-1497
pubmed: 28176275
Expert Opin Investig Drugs. 2017 Feb;26(2):175-185
pubmed: 27927041
Hum Genomics. 2010 Oct;5(1):30-55
pubmed: 21106488
Pharmaceuticals (Basel). 2021 Jul 25;14(8):
pubmed: 34451813
Parkinsonism Relat Disord. 2016 Jan;22:68-73
pubmed: 26631952
Ann Clin Transl Neurol. 2019 Feb 15;6(3):615-619
pubmed: 30911585
Cell Immunol. 2018 May;327:77-82
pubmed: 29478949
Nat Biotechnol. 2010 May;28(5):431
pubmed: 20458308
J Neurol. 2019 Nov;266(11):2605-2619
pubmed: 30377818
Mov Disord. 2018 Feb;33(2):282-288
pubmed: 29205509
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399
pubmed: 22355802
Aging Dis. 2019 Oct 1;10(5):1130-1139
pubmed: 31595207
Mov Disord. 2016 Jul;31(7):995-1003
pubmed: 26999434
Acta Neurol Scand. 2007 Dec;116(6):374-9
pubmed: 17986095
Front Neurosci. 2018 Aug 30;12:612
pubmed: 30214392
J Parkinsons Dis. 2021;11(2):395-404
pubmed: 33682731
JAMA Neurol. 2016 Nov 01;73(11):1316-1324
pubmed: 27668667
Am J Manag Care. 2010 Mar;16 Suppl Implications:S87-93
pubmed: 20297871

Auteurs

Lars Tönges (L)

Department of Neurology, Ruhr-University Bochum, St. Josef Hospital, Gudrunstr. 56, 44791, Bochum, Germany. lars.toenges@ruhr-uni-bochum.de.
Center for Protein Diagnostics (ProDi), Ruhr University Bochum, 44801, Bochum, Nordrhein-Westfalen, Germany. lars.toenges@ruhr-uni-bochum.de.

Carsten Buhmann (C)

Department of Neurology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Stephan Klebe (S)

Department of Neurology, University Hospital Essen, 45147, Essen, Germany.

Jochen Klucken (J)

Department of Digital Medicine, University Luxembourg, LCSB, L-4367, Belval, Luxembourg.
Digital Medicine Research Group, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Centre Hospitalier de Luxembourg, Digital Medicine Research Clinic, L-1210, Luxembourg, Luxembourg.

Eun Hae Kwon (EH)

Department of Neurology, Ruhr-University Bochum, St. Josef Hospital, Gudrunstr. 56, 44791, Bochum, Germany.

Thomas Müller (T)

Department of Neurology, St. Joseph Hospital Berlin-Weissensee, 13088, Berlin, Germany.

David J Pedrosa (DJ)

Department of Neurology, Universitätsklinikum Gießen and Marburg, Marburg Site, 35043, Marburg, Germany.
Center of Mind, Brain and Behaviour (CMBB), Philipps-Universität Marburg, 35043, Marburg, Germany.

Nils Schröter (N)

Department of Neurology and Clinical Neuroscience, University of Freiburg, 79106, Freiburg, Germany.

Peter Riederer (P)

Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Clinic and Policlinic for Psychiatry, 97080, Wuerzburg, Germany.
University of Southern Denmark Odense, 5000, Odense, Denmark.

Paul Lingor (P)

School of Medicine, Klinikum Rechts Der Isar, Department of Neurology, Technical University of Munich, 81675, München, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH